| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2973193 | The Journal of Heart and Lung Transplantation | 2007 | 8 Pages |
Abstract
CRP may be used as a surrogate parameter for interleukin-6 and complement activation in moderate CHF. CRP in combination with BNP identifies a high-risk group with a tendency for poor outcome not discriminated by cardiac function.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
H. MD, P. MD, G.A. MD, R. PhD, B. MD, O. MD, R. MD,